Co-Authors
                            
                            
                                This is a "connection" page, showing publications co-authored by Rosemary Zuna and Michael Gold.
                            
                            
                            
                                
                                    
                                            
    
        
        
        
            Connection Strength
            
                
            
            1.374
         
        
        
     
 
    
        
        - 
            Papillary adenocarcinoma of unknown primary in a young woman: a clinicopathologic correlation conference from the University of Oklahoma College of Medicine. J Okla State Med Assoc. 1999 Nov; 92(11):529-34.
            
            
                Score: 0.165
             
- 
            Cytologic patterns of cervical adenocarcinomas with emphasis on factors associated with underdiagnosis. Cancer Cytopathol. 2018 11; 126(11):950-958.
            
            
                Score: 0.154
             
- 
            Distribution of cell types differs in Papanicolaou tests of squamous cell carcinomas and adenocarcinomas. J Am Soc Cytopathol. 2017 Jan - Feb; 6(1):10-15.
            
            
                Score: 0.132
             
- 
            Factors associated with reduced accuracy in Papanicolaou tests for patients with invasive cervical cancer. Cancer Cytopathol. 2014 Sep; 122(9):694-701.
            
            
                Score: 0.113
             
- 
            HPV16 variant lineage, clinical stage, and survival in women with invasive cervical cancer. Infect Agent Cancer. 2011 Oct 28; 6:19.
            
            
                Score: 0.095
             
- 
            Cervical dysplasia among women over 35 years of age. Am J Obstet Gynecol. 2008 Nov; 199(5):471.e1-5.
            
            
                Score: 0.075
             
- 
            A LEEP cervical conization is rarely indicated for a two-step discrepancy. J Low Genit Tract Dis. 2007 Jul; 11(3):134-7.
            
            
                Score: 0.070
             
- 
            Association of HPV35 with cervical carcinogenesis among women of African ancestry: Evidence of viral-host interaction with implications for disease intervention. Int J Cancer. 2020 11 15; 147(10):2677-2686.
            
            
                Score: 0.043
             
- 
            A prospective study of risk-based colposcopy demonstrates improved detection of cervical precancers. Am J Obstet Gynecol. 2018 06; 218(6):604.e1-604.e8.
            
            
                Score: 0.037
             
- 
            Diagnosis of Cervical Precancers by Endocervical Curettage at Colposcopy of Women With Abnormal Cervical Cytology. Obstet Gynecol. 2017 12; 130(6):1218-1225.
            
            
                Score: 0.036
             
- 
            Comparison of Colposcopic Impression Based on Live Colposcopy and Evaluation of Static Digital Images. J Low Genit Tract Dis. 2016 Apr; 20(2):154-61.
            
            
                Score: 0.032
             
- 
            Multiple biopsies and detection of cervical cancer precursors at colposcopy. J Clin Oncol. 2015 Jan 01; 33(1):83-9.
            
            
                Score: 0.029
             
- 
            Evaluation of clinical performance of a novel urine-based HPV detection assay among women attending a colposcopy clinic. J Clin Virol. 2014 Aug; 60(4):414-7.
            
            
                Score: 0.028
             
- 
            Comparison of human papillomavirus detections in urine, vulvar, and cervical samples from women attending a colposcopy clinic. J Clin Microbiol. 2014 Jan; 52(1):187-92.
            
            
                Score: 0.027
             
- 
            Chromosomal gains measured in cytology samples from women with abnormal cervical cancer screening results. Gynecol Oncol. 2013 Sep; 130(3):595-600.
            
            
                Score: 0.026
             
- 
            Reproducibility of linear array for human papillomavirus genotyping. J Clin Microbiol. 2013 Feb; 51(2):625-8.
            
            
                Score: 0.026
             
- 
            The role of co-factors in the progression from human papillomavirus infection to cervical cancer. Gynecol Oncol. 2013 Feb; 128(2):265-70.
            
            
                Score: 0.025
             
- 
            Tubal ligation frequency in Oklahoma women with cervical cancer. Gynecol Oncol. 2012 Nov; 127(2):278-82.
            
            
                Score: 0.025
             
- 
            Performance of p16/Ki-67 immunostaining to detect cervical cancer precursors in a colposcopy referral population. Clin Cancer Res. 2012 Aug 01; 18(15):4154-62.
            
            
                Score: 0.025
             
- 
            Heterogeneity of high-grade cervical intraepithelial neoplasia related to HPV16: implications for natural history and management. Int J Cancer. 2013 Jan 01; 132(1):148-54.
            
            
                Score: 0.025
             
- 
            Molecular mapping of high-grade cervical intraepithelial neoplasia shows etiological dominance of HPV16. Int J Cancer. 2012 Sep 15; 131(6):E946-53.
            
            
                Score: 0.024
             
- 
            Human papillomavirus load measured by Linear Array correlates with quantitative PCR in cervical cytology specimens. J Clin Microbiol. 2012 May; 50(5):1564-70.
            
            
                Score: 0.024
             
- 
            Clinical and pathological heterogeneity of cervical intraepithelial neoplasia grade 3. PLoS One. 2012; 7(1):e29051.
            
            
                Score: 0.024
             
- 
            Multiple human papillomavirus genotype infections in cervical cancer progression in the study to understand cervical cancer early endpoints and determinants. Int J Cancer. 2009 Nov 01; 125(9):2151-8.
            
            
                Score: 0.021
             
- 
            Accuracy of cervical specimens obtained for biomarker studies in women with CIN3. Gynecol Oncol. 2009 Dec; 115(3):493-6.
            
            
                Score: 0.020
             
- 
            Grading the severity of cervical neoplasia based on combined histopathology, cytopathology, and HPV genotype distribution among 1,700 women referred to colposcopy in Oklahoma. Int J Cancer. 2009 Feb 15; 124(4):964-9.
            
            
                Score: 0.020
             
- 
            Human papillomavirus cofactors by disease progression and human papillomavirus types in the study to understand cervical cancer early endpoints and determinants. Cancer Epidemiol Biomarkers Prev. 2009 Jan; 18(1):113-20.
            
            
                Score: 0.019
             
- 
            Evaluation of linear array human papillomavirus genotyping using automatic optical imaging software. J Clin Microbiol. 2008 Aug; 46(8):2759-65.
            
            
                Score: 0.019
             
- 
            Towards improved biomarker studies of cervical neoplasia: effects of precolposcopic procedures on gene expression patterns. Diagn Mol Pathol. 2005 Jun; 14(2):59-64.
            
            
                Score: 0.015